Heading to NEXT Pharma? Join us for our session

Date LocationDubrovnik, Croatia

Maximising global programmes by partnering Medical Affairs & Commercial Activities

Join us for an insightful discussion on enhancing collaboration between Medical Affairs and Commercial teams to streamline content creation, global launches, materials reuse. We will explore what technologies should be used, identify challenges in successful product launch, and the transformative power AI has for global digital strategies now and in the future.

Michelle Bridenbaker
Michelle Bridenbaker Global Medical Information Lead at Recordati / Vice President at MILE
Jamie McNally
Jamie McNally Executive Director, Head of Omnichannel Activation at Astellas
Courtney Marino
Courtney Marino Director, Content Operations Lead at Astellas
Christine Buggle
Christine Buggle Senior Director at TransPerfect
background image
How did you hear about us?
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Webinar cover image
How did you hear about us?
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Check out last year's NEXT Pharma Session

Beyond Borders: Navigating the Complexities of Omnichannel Content Strategy for Global and Local Markets

Hosted by Christine Buggle, Senior Director at TransPerfect Life Sciences, in discussion with Ewelina Knigawka, Executive Director of Content and Partnership Excellence at Novartis, and Scott Dille, Digital Content Lead at Novo Nordisk, this session outlined key considerations when implementing a successful global to local omnichannel strategy.

Additional topics in the conversation included:

  • Establishing a global governance structure for omnichannel: Ensuring a consistent and high-quality customer experience across markets.
  • Balancing standardization and variation: Consistency and efficiency through standardization, while fostering innovation and capturing local market needs effectively.
  • Measuring success with data-driven insights: Tracking relevant KPIs, utilizing dashboards, and prioritizing customer experience, regulatory compliance, and timely content delivery.

Download our eBrochure to learn about our Medical Information Solutions

Thought Leadership

6 Pathways to Take Your MT Strategy to the Next Level in 2024

With 2024 well underway, innovators in the global life sciences and pharmaceutical industries continue to question how to maximize efficiencies and reduce complexities in clinical and regulatory content development and localization. As part of the broader technological roadmap, AI and automation remain front and center as key players in taking these workflows to new heights. Machine translation (MT) is expected to directly impact and transform approaches to multilingual...
6 Pathways to Take Your MT Strategy to the Next Level in 2024

Unlocking the Power of AI and Machine Learning in Life Sciences

Life sciences companies are putting artificial intelligence (AI) and machine learning (ML) into practice, realizing its potential to revolutionize adverse event detection, diagnostics, and more. For AI and ML to be truly effective, you need to give context to your data, teaching ...

Pfizer - Unlocking the Power of GlobalLink Within Pfizer Medical Information

GlobalLink and AI enable faster, better decisions in response to patient queries. ...

Driving Success in Omnichannel Content Strategies for Global and Local Markets

Introduction:   In the rapidly evolving landscape of life sciences marketing, implementing an effective omnichannel strategy is crucial to driving positive customer experiences and increasing engagement. By seamlessly integrating multiple channels and considering...

Omnichannel Marketing for the Pharmaceutical Industry

With rapid globalization and expanded marketing efforts, pharmaceutical organizations are discovering that pivoting from multichannel marketing to omnichannel marketing is key to revolutionizing patient engagement. Through tailored experiences across relevant channels, your teams ...

Why Automate the Literature Monitoring Process?

A key concern for pharma companies is keeping a close eye on publications that might mention their product and its potential impact on the public. These publications can be extremely dense in volume, commanding careful review of multiple documents across several different...

Novo Nordisk Delivers Multilingual Digital Experiences Through GlobalLink and Adobe

"Before GlobalLink for AEM we had to manage translation processes outside AEM, adding an extra layer of processes and approval flows into our work stream. Now it all happens within the same system, making translation and approvals flows smoother." ...